1. Home
  2. CTRI vs JANX Comparison

CTRI vs JANX Comparison

Compare CTRI & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTRI
  • JANX
  • Stock Information
  • Founded
  • CTRI 1909
  • JANX 2017
  • Country
  • CTRI United States
  • JANX United States
  • Employees
  • CTRI N/A
  • JANX N/A
  • Industry
  • CTRI
  • JANX Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTRI
  • JANX Health Care
  • Exchange
  • CTRI Nasdaq
  • JANX Nasdaq
  • Market Cap
  • CTRI 1.8B
  • JANX 1.6B
  • IPO Year
  • CTRI 2024
  • JANX 2021
  • Fundamental
  • Price
  • CTRI $20.91
  • JANX $26.02
  • Analyst Decision
  • CTRI Hold
  • JANX Strong Buy
  • Analyst Count
  • CTRI 7
  • JANX 7
  • Target Price
  • CTRI $19.00
  • JANX $94.29
  • AVG Volume (30 Days)
  • CTRI 281.6K
  • JANX 974.6K
  • Earning Date
  • CTRI 05-07-2025
  • JANX 05-20-2025
  • Dividend Yield
  • CTRI N/A
  • JANX N/A
  • EPS Growth
  • CTRI N/A
  • JANX N/A
  • EPS
  • CTRI N/A
  • JANX N/A
  • Revenue
  • CTRI $2,637,229,000.00
  • JANX $10,588,000.00
  • Revenue This Year
  • CTRI $3.93
  • JANX N/A
  • Revenue Next Year
  • CTRI $4.82
  • JANX $250.58
  • P/E Ratio
  • CTRI N/A
  • JANX N/A
  • Revenue Growth
  • CTRI N/A
  • JANX 30.99
  • 52 Week Low
  • CTRI $14.46
  • JANX $22.52
  • 52 Week High
  • CTRI $28.65
  • JANX $71.71
  • Technical
  • Relative Strength Index (RSI)
  • CTRI N/A
  • JANX 41.70
  • Support Level
  • CTRI N/A
  • JANX $24.13
  • Resistance Level
  • CTRI N/A
  • JANX $33.97
  • Average True Range (ATR)
  • CTRI 0.00
  • JANX 1.93
  • MACD
  • CTRI 0.00
  • JANX -0.51
  • Stochastic Oscillator
  • CTRI 0.00
  • JANX 29.57

About CTRI Centuri Holdings Inc. Common Stock

Centuri Holdings Inc is a pure-play North American utility infrastructure services company that partners with regulated utilities to maintain, upgrade and expand the energy network that powers millions of homes and businesses. Its service offerings primarily consist of the modernization of utility infrastructure through the maintenance, retrofitting and installation of electric and natural gas distribution networks to meet current and future demands while also preparing systems for the transition to clean energy sources. They operate under two primary lines of business which includes Gas Utility Services and Electric Utility Services it is also their two reportable segments as well.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: